Abstract
Compared to other monoamine neurotransmitters, information on the association between the histaminergic system and neuropsychiatric disorders is scarce, resulting in a lack of histamine-related treatment for these disorders. The current chapter tries to combine information obtained from genetic studies, neuroimaging, post-mortem human brain studies and cerebrospinal fluid measurements with data from recent clinical trials on histamine receptor agonists and antagonists, with a view to determining the possible role of the histaminergic system in neuropsychiatric disorders and to pave the way for novel histamine-related therapeutic strategies.
| Original language | English |
|---|---|
| Pages (from-to) | 259-276 |
| Journal | Handbook of Experimental Pharmacology |
| Volume | 241 |
| DOIs | |
| Publication status | Published - 2017 |
Keywords
- Journal Article